Cambridge Investment Research Advisors
PBYI icon

Cambridge Investment Research Advisors’s Puma Biotechnology PBYI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80K Sell
12,563
-46,754
-79% -$301K ﹤0.01% 3816
2025
Q4 		$353K Buy
59,317
+8,494
+17% +$45.1K ﹤0.01% 3035
2025
Q3 		$270K Buy
+50,823
New +$216K ﹤0.01% 3199
2022
Q4 		– Sell
-14,945
Closed -$35K – 3187
2022
Q3 		$35K Buy
+14,945
New +$43.6K ﹤0.01% 2968
2018
Q1 		– Sell
-12,632
Closed -$1.25M – 2213
2017
Q4 		$1.25M Hold
12,632
– – 0.01% 804
2017
Q3 		$1.51M Buy
+12,632
New +$1.17M 0.02% 642

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return